Ilika’s larger solid‑state cells signal a turning point in next‑gen battery tech

Ilika Plc

Ilika has begun shipping 10 amp-hour solid-state battery prototypes to automotive customers and partners in adjacent sectors, including defence and industrial systems. These new cells represent a fivefold increase in capacity from its earlier generation, pushing performance into a range that starts to matter in real-world applications.

What sets this milestone apart is that the larger cells have been produced using an automated pilot line, not hand-assembled in a lab. This facility, completed earlier in the year, has already achieved yields of over 90%,an unusually high figure for early-stage solid-state production. That manufacturing consistency gives Ilika a foundation from which to scale, and sends a strong signal that its technology is maturing beyond the research phase.

The decision to automate early anchors a roadmap toward industrialisation and creates optionality around licensing, joint ventures or in-house expansion. The production capability reinforces confidence in the quality of the output, as automation tightens control over variables like layer thickness, electrolyte distribution and interfacial stability, all critical in solid-state designs.

Crucially, the 10 amp-hour format opens the door to subsystem-level trials in electric vehicles, especially for modules intended for premium segments where safety, weight and energy density carry a premium.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Search